http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#Head http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#assertion http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#provenance http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#pubinfo http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#assertion http://purl.obolibrary.org/obo/DOID_1558 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1558 http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB14125 http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#association http://www.w3.org/2000/01/rdf-schema#label "Benazepril hydrochloride tablets are contraindicated in patients: who are hypersensitive to benazepril or to any other ACE inhibitor with a history of angioedema with or without previous ACE inhibitor treatment Benazepril hydrochloride tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer benazepril hydrochloride tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [see Warnings and Precautions (5.2) Do not coadminister aliskiren with angiotensin receptor blockers, ACE inhibitors, including benazepril hydrochloride tablets in patients with diabetes [see Drug Interactions (7.4) Angioedema or history of hereditary or idiopathic angioedema ( 4 Hypersensitivity ( 4 Coadministration with aliskiren in patients with diabetes ( 4" http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB14125 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#provenance http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#pubinfo http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#sig http://purl.org/nanopub/x/hasSignature REu5cT6GSQlz7beCfElVMB5suGKEJP9+1to4+h9GOnksXBecoiSlb0R29gkuVOeTemb+2BW4ypilUjBHUaWVXuoROvoVamgXbfzjPQmjYCPs+mzQxLgTx7JI8dNwEOetuxhW0BCVUXOWCEdZamuR4WoaSxco+X9oXsF2OjgmK3o= http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE http://purl.org/dc/terms/created 2021-08-23T12:51:12.336+02:00 http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA91FULNrg0uNy9D0w981ZIIzwN35MqeTtrKP1dXpZTPE https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY